L. Dousset
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers 10
- Cutaneous Melanoma Detection and Management 6
- Dermatology top 5%
- Cancer and Skin Lesions 6
- Genetics top 10%
-
- melanin and skin pigmentation 3
-
- Nonmelanoma Skin Cancer Studies 6
-
- Cancer, Hypoxia, and Metabolism 4
-
- Melanoma and MAPK Pathways 4
- Hedgehog Signaling Pathway Studies 3
- Co-authors
- S. PreyCaroline DutriauxAlain Taı̈ebAnne Pham‐LedardM. Beylot‐BarryKatia BonifaceJulien SénéschalHamid Rezvani
- Cited by
- OncologyDermatologyGenetics
- Journals
- Journal of Investigative Dermatology (3 papers)Critical Reviews in Oncology/Hematology (2 papers)Acta Dermato Venereologica (2 papers)
- Partner nations
- FranceAustraliaUnited States
In The Last Decade
L. Dousset
30 papers receiving 615 citations
Peers
Comparison fields: 5 of 74
- Oncology 344
- Dermatology 107
- Genetics 89
- Immunology 108
- Cell Biology 65
Countries citing papers authored by L. Dousset
This map shows the geographic impact of L. Dousset's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Dousset with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Dousset more than expected).
Fields of papers citing papers by L. Dousset
This network shows the impact of papers produced by L. Dousset. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Dousset. The network helps show where L. Dousset may publish in the future.
Co-authorship network
The 25 scholars most cited alongside L. Dousset, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 3 | |
| 4 | 2024 | 5 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 4 | |
| 7 | 2023 | 2 | |
| 8 | 2021 | 15 | |
| 9 | 2021 | 4 | |
| 10 | 2021 | 15 | |
| 11 | 2020 | 1 | |
| 12 | 2020 | 4 | |
| 13 | 2019 | 1 | |
| 14 | 2019 | 5 | |
| 15 | 2019 | 16 | |
| 16 | 2019 | 23 | |
| 17 | 2017 | 208 | |
| 18 | 2017 | 28 | |
| 19 | 2017 | 112 | |
| 20 | 2015 | 10 |
About L. Dousset
L. Dousset is a scholar working on Dermatology, Oncology and Cancer Research, having authored 34 papers that have together received 618 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (10 papers), Cancer and Skin Lesions (6 papers), Nonmelanoma Skin Cancer Studies (6 papers), Cutaneous Melanoma Detection and Management (6 papers), Cancer, Hypoxia, and Metabolism (4 papers), Melanoma and MAPK Pathways (4 papers), Hedgehog Signaling Pathway Studies (3 papers) and melanin and skin pigmentation (3 papers). The work is most often cited by research in Oncology (344 citations), Dermatology (107 citations) and Genetics (89 citations). L. Dousset has collaborated with scholars based in France, Australia and United States. Frequent co-authors include S. Prey, Caroline Dutriaux, Alain Taı̈eb, Anne Pham‐Ledard, M. Beylot‐Barry, Katia Boniface, Julien Sénéschal, Hamid Rezvani, Thomas Barnetche and Marie Kostine. Their work appears in journals such as Journal of Investigative Dermatology, Critical Reviews in Oncology/Hematology, Acta Dermato Venereologica, Journal of the American Academy of Dermatology and Clinica Chimica Acta.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.